The USA; as represented by the SECRETARY; DEPT. OF HEALTH AND HUMAN SERVICES
发明人:
Richard M. Siegel,Francoise Meylan,Yun-Jeong Song
申请号：
US15872592
公开号：
US10590201B2
申请日:
2018.01.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods and compositions for treating inflammatory or autoimmune diseases in a subject comprising blocking the interaction between DR3 and TL1A. In the methods of treating inflammatory or autoimmune disease, the inflammatory or autoimmune disease can be an autoimmune disease with a T cell component, including asthma, multiple sclerosis, rheumatoid arthritis, type 1 diabetes, graft versus host disease or inflammatory bowel disease.
